Clinic-based real-world analysis of amyloid PET positivity and MRI markers across subjective cognitive decline, mild cognitive impairment, and early Alzheimer's disease.
- DOI
- 10.1177/13872877261490596
- Published
- 2026 Sep 23
- Container
- Journal of Alzheimer's disease : JAD
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/13872877261490596,
title = {Clinic-based real-world analysis of amyloid PET positivity and MRI markers across subjective cognitive decline, mild cognitive impairment, and early Alzheimer's disease.},
author = {Arai H and Aiba S and Yamamoto H and Akiba Y and Takayama J and Arai R},
year = {2026},
journal = {Journal of Alzheimer's disease : JAD},
doi = {10.1177/13872877261490596},
url = {https://doi.org/10.1177/13872877261490596}
}RIS
TY - JOUR TI - Clinic-based real-world analysis of amyloid PET positivity and MRI markers across subjective cognitive decline, mild cognitive impairment, and early Alzheimer's disease. AU - Arai H AU - Aiba S AU - Yamamoto H AU - Akiba Y AU - Takayama J AU - Arai R PY - 2026 JO - Journal of Alzheimer's disease : JAD DO - 10.1177/13872877261490596 UR - https://doi.org/10.1177/13872877261490596 ER -
APA
H, A., S, A., H, Y., Y, A., J, T., & R, A. (2026). Clinic-based real-world analysis of amyloid PET positivity and MRI markers across subjective cognitive decline, mild cognitive impairment, and early Alzheimer's disease.. Journal of Alzheimer's disease : JAD. https://doi.org/10.1177/13872877261490596
Source records
- pubmed · retrieved 2026-09-25T19:08:27.519Z